| Financial Year |
March 31 2023 |
| Monetary Funds |
3,512,615,557.36 |
| Held-for-trading Financial Assets |
650,000,000.00 |
| Notes Receivable |
35,673,407.76 |
| Accounts Receivable |
5,607,887,425.93 |
| Advances to Suppliers |
235,893,895.46 |
| Other Receivables |
363,659,094.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
905,423,642.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
553,149,272.64 |
| Other Current Assets |
426,729,494.83 |
| Total Current Assets |
12,522,533,976.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
843,004,039.57 |
| Long-term Equity Investment |
678,840,407.76 |
| Investment Properties |
26,699,049.86 |
| Fixed Assetes |
2,231,357,764.27 |
| Under-construction Projects |
113,968,429.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,145,618,956.00 |
| R&D expenses |
30,338,218.08 |
| Goodwill |
5,737,881,463.75 |
| Long-Term Deferred and Prepaid Expenses |
37,022,171.77 |
| Deferred Income Tax Assets |
116,460,653.81 |
| Other Non-Current Assets |
238,003,778.63 |
| Sub-Total of Non-Current Assets |
16,244,098,675.30 |
| Total Assets |
28,766,632,651.37 |
| Short-Term Loans |
264,714,703.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,263,985,342.32 |
| Accounts Payable |
2,661,883,692.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
296,915,120.54 |
| Taxes Payable |
90,470,947.89 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
583,052,038.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
543,269,254.37 |
| Other Current Liabilities |
39,083,774.42 |
| Sub-Total of Current Liabilities |
7,037,937,158.98 |
| Long-term Loans |
1,962,045,309.14 |
| Bonds Payable |
1,324,152,619.83 |
| Long-Term Accounts Payable |
325,211,791.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,754,354.69 |
| Deferred Income Tax Liabilities |
52,182,357.98 |
| Other Non-Current Liabilities |
8,333,333.33 |
| Sub-Total of Non-Current Liabilities |
3,821,041,848.35 |
| Total Liabilities |
10,858,979,007.33 |
| Paid-In Capital(Or Share Stock) |
3,179,505,559.00 |
| Capital Surplus |
9,662,511,254.48 |
| Surplus Reserve |
316,958,351.42 |
| LESS:Treasury Stock |
94,132,795.17 |
| Undistributed Profits |
4,117,849,237.83 |
| Minority Stockholder's Interest |
462,675,694.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,444,977,949.36 |
| Owner's Equity（Stockholder's Equity） |
17,907,653,644.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
28,766,632,651.37 |
